Estrogen receptor 1 gene polymorphisms are associated with metabolic syndrome in postmenopausal women in China.

BMC Endocrine Disorders
Lingxia ZhaoGuoping Zheng

Abstract

Metabolic syndrome (MetS) includes obesity, diabetes, dyslipidemia and hypertension. Its incidence is rapidly increasing worldwide, particularly in postmenopausal women. Estrogens regulate glucose homeostasis and lipid metabolism via estrogen receptors 1 (ESR1) and 2 (ESR2). The current study aimed to elucidate associations of MetS with ESR1 and ESR2 gene polymorphisms in postmenopausal Chinese women. This case-control study included 304 postmenopausal women (154 and 150 control and MetS patients, respectively). Clinical indicators related to MetS were assessed. Two ESR1 (PvuII and XbaI) and two ESR2 (RsaI and AluI) polymorphisms were evaluated by polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis. ESR1 polymorphisms were significantly different between MetS patients and healthy controls. G allele frequency for the XbaI polymorphism was significantly higher in patients than in control patients (p = 0.004, OR = 1.610, 95%CI 1.169-2.18). The haplotypes A-T (p = 0.015) and G-C (p = 0.024) showed significant differences. The minor alleles of the XbaI and PvuII gene polymorphisms in both homozygous and heterozygous forms showed associations with elevated waist circumference, fasting serum insulin and H...Continue Reading

References

Jan 8, 1999·Biochemical and Biophysical Research Communications·S AndòE Surmacz
Jun 11, 1999·The New England Journal of Medicine·M E Mendelsohn, R H Karas
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·P A HeineP S Cooke
Feb 24, 2001·Journal of Human Genetics·S OgawaS Inoue
Dec 31, 2003·Molecular Psychiatry·M NilssonK Dahlman-Wright
Aug 16, 2005·Archives of Medical Research·Antonio de Padua MansurJosé Antonio F Ramires
Jan 6, 2006·Journal of Atherosclerosis and Thrombosis·Paul ZimmetJonathan Shaw
Jan 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rodrigo P A BarrosJan-Ake Gustafsson
Oct 3, 2006·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Luis A HidalgoAngelica Huc
Jun 15, 2007·Journal of Gastroenterology and Hepatology·Geoffrey C FarrellUNKNOWN Asia-Pacific Working Party on NAFLD
Sep 21, 2007·International Journal of Impotence Research·A PonholzerS Madersbacher
May 1, 2008·American Journal of Public Health·Rosemarie G Ramos, Kenneth Olden
Aug 14, 2008·American Journal of Physiology. Endocrinology and Metabolism·Galyna BryzgalovaKarin Dahlman-Wright
Nov 27, 2008·Metabolic Syndrome and Related Disorders·Alessandra C GoulartKathryn M Rexrode
Sep 10, 2010·Clinical Pharmacology and Therapeutics·D F HayesUNKNOWN Consortium on Breast Cancer Pharmacogenomics (COBRA)
Sep 13, 2011·Cell Metabolism·Rodrigo P A Barros, Jan-Åke Gustafsson
Apr 27, 2012·Journal of Nutrition and Metabolism·Akl C FahedGeorges M Nemer
Feb 16, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Sankar D NavaneethanJoseph V Nally
Jul 3, 2013·Metabolism: Clinical and Experimental·Maivel H GhattasDina M Abo-Elmatty

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
hormone replacement
PCR

Software Mentioned

SHEsis
R package

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.